Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum Disorders

NCT06068829 · clinicaltrials.gov ↗

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Neuromyelitis Optica Spectrum Disorders

Interventions

DRUG: Inebilizumab
DRUG: Rituximab(RTX)

Sponsor

Feng Jinzhou